Literature DB >> 31483687

Effect of Zileuton Treatment on Sinonasal Quality of Life in Patients with Aspirin-Exacerbated Respiratory Disease.

Saangyoung E Lee1, Douglas R Farquhar2, Katherine N Adams2, Maheer M Masood1, Brent A Senior2, Brian D Thorp2, Adam M Zanation2, Charles S Ebert2.   

Abstract

Entities:  

Keywords:  aspirin-exacerbated respiratory disease; functional endoscopic sinus surgery; leukotriene; quality of life; questionnaire; revision surgery; rhinology; rhinosinusitis disability index; sinusitis; zileuton

Mesh：

Substances：

Year:  2019        PMID： 31483687      PMCID： PMC6843740          DOI： 10.1177/1945892419873211

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN： 1945-8932            Impact factor:   2.467


× No keyword cloud information.
  17 in total

1.  Revision rates after endoscopic sinus surgery: a recurrence analysis.

Authors:  Daniel Mendelsohn; Goran Jeremic; Erin D Wright; Brian W Rotenberg
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-03       Impact factor: 1.547

2.  The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.

Authors:  Andrew A White; Donald D Stevenson; Ronald A Simon
Journal:  Ann Allergy Asthma Immunol       Date:  2005-10       Impact factor: 6.347

3.  Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial.

Authors:  Thomas R Schneider; Christina B Johns; Marina L Palumbo; Katherine C Murphy; Katherine N Cahill; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2017-11-10

4.  Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease.

Authors:  Von Ta; Andrew A White
Journal:  J Allergy Clin Immunol Pract       Date:  2015-04-07

5.  Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics.

Authors:  J D Pauls; R A Simon; P J Daffern; D D Stevenson
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

Review 6.  Antileukotrienes in upper airway inflammatory diseases.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Kagan Ipci; Ethem Şahin
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

7.  Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

Authors:  Harold Nelson; James Kemp; William Berger; Jonathon Corren; Thomas Casale; Louise Dube; Karen Walton-Bowen; Nicole LaVallee; Miganush Stepanians
Journal:  Ann Allergy Asthma Immunol       Date:  2007-08       Impact factor: 6.347

8.  Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.

Authors:  Andrew P Hope; Katharine A Woessner; Ronald A Simon; Donald D Stevenson
Journal:  J Allergy Clin Immunol       Date:  2008-12-03       Impact factor: 10.793

9.  The development of the Rhinosinusitis Disability Index.

Authors:  M S Benninger; B A Senior
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-11

Review 10.  The role of leukotriene inhibitors in patients with paranasal sinus disease.

Authors:  Steven M Parnes
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2003-06       Impact factor: 2.064
View more
  1 in total

Review 1.  Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients.

Authors:  Rik J L van der Lans; Wytske J Fokkens; Sietze Reitsma
Journal:  Front Allergy       Date:  2021-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.